Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Veronique, Vergé"'
Autor:
Jean‐Marie Michot, Cyril Quivoron, Clémentine Sarkozy, Alina Danu, Julien Lazarovici, Khalil Saleh, Yolla El‐Dakdouki, Vincent Goldschmidt, Camille Bigenwald, Matteo Dragani, Rastislav Bahleda, Capucine Baldini, Julia Arfi‐Rouche, Patricia Martin‐Romano, Lambros Tselikas, Anas Gazzah, Antoine Hollebecque, Ludovic Lacroix, David Ghez, Veronique Vergé, Christophe Marzac, Sophie Cotteret, Wassila Rahali, Jean‐Charles Soria, Christophe Massard, Olivier A. Bernard, Peggy Dartigues, Valérie Camara‐Clayette, Vincent Ribrag
Publikováno v:
American Journal of Hematology. 98:645-657
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::83c09f85453cac881c334c43ddbe2644
https://doi.org/10.1002/ajh.26835
https://doi.org/10.1002/ajh.26835
Autor:
Jean-Marie, Michot, Cyril, Quivoron, Clémentine, Sarkozy, Alina, Danu, Julien, Lazarovici, Khalil, Saleh, Yolla, El-Dakdouki, Vincent, Goldschmidt, Camille, Bigenwald, Matteo, Dragani, Rastislav, Bahleda, Capucine, Baldini, Julia, Arfi-Rouche, Patricia, Martin-Romano, Lambros, Tselikas, Anas, Gazzah, Antoine, Hollebecque, Ludovic, Lacroix, David, Ghez, Veronique, Vergé, Christophe, Marzac, Sophie, Cotteret, Wassila, Rahali, Jean-Charles, Soria, Christophe, Massard, Olivier A, Bernard, Peggy, Dartigues, Valérie, Camara-Clayette, Vincent, Ribrag
Publikováno v:
American journal of hematology.
Advances in molecular profiling of newly diagnosed diffuse large cell B lymphoma (DLBCL) have recently refine genetic subgroups. Genetic subgroups remain undetermined at the time of relapse or refractory (RR) disease. This study aims to decipher gene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::aa1f2f1bd60bfe09f1265db9440e311b
https://pubmed.ncbi.nlm.nih.gov/36606708
https://pubmed.ncbi.nlm.nih.gov/36606708
Autor:
Julia Arfi-Rouche, Julien Rossignol, Peggy Dartigues, Vincent Ribrag, Elie El Rassy, Toni Ibrahim, Julien Lazarovici, Jean-Marie Michot, Alina Danu, David Ghez, Veronique Vergé
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:e373-e380
Introduction After failure of frontline therapy, patients with relapsed/refractory diffuse large B-cell lymphoma (RR-DLBCL) that does not respond to first-line salvage chemotherapy can be recommended second-line salvage chemotherapy. The available li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81f51e95e4cd673db50983e4a4a7ace8
https://doi.org/10.1016/j.clml.2020.11.008
https://doi.org/10.1016/j.clml.2020.11.008
Autor:
Vincent Marmouset, Justine Decroocq, Sylvain Garciaz, Gabriel Etienne, Amine Belhabri, Sarah Bertoli, Lauris Gastaud, Celestine Simand, Sylvain Chantepie, Madalina Uzunov, Alexis Genthon, Celine Berthon, Edmond Chiche, Pierre-Yves Dumas, Jacques Vargaftig, Géraldine Salmeron, Emilie Lemasle, Emmanuelle Tavernier, Jeremy Delage, Marion Loirat, Nadine Morineau, Felix Blanc-Durand, Patricia Pautier, Veronique Vergé, Nathalie Auger, Myrtille Thomas, Laetitia Stefani, Marion Lepelley, Thomas Boyer, Sylvain Thepot, Marie-Pierre Gourin, Pascal Bourquard, Matthieu Duchmann, Pierre Morice, Mauricette Michallet, Lionel Ades, Pierre Fenaux, Christian Recher, Hervé Dombret, Arnaud Pages, Christophe Marzac, Alexandra Leary, Jean-Baptiste Micol
Publikováno v:
Blood
Blood, 2022, 140 (Supplement 1), pp.12335-12338. ⟨10.1182/blood-2022-163478⟩
Clinical Cancer Research
Clinical Cancer Research, 2022, pp.CCR-22-1622. ⟨10.1158/1078-0432.CCR-22-1622⟩
Blood, 2022, 140 (Supplement 1), pp.12335-12338. ⟨10.1182/blood-2022-163478⟩
Clinical Cancer Research
Clinical Cancer Research, 2022, pp.CCR-22-1622. ⟨10.1158/1078-0432.CCR-22-1622⟩
Purpose: To provide insights into the diagnosis and management of therapy-related myeloid neoplasms (t-MN) following PARP inhibitors (PARPi). Experimental Design: In a French cancer center, we identified and described the profiles of 13 t-MN diagnose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdd7b9652a9ac251a3037cc92b20b4ae
https://pubmed.ncbi.nlm.nih.gov/36201165
https://pubmed.ncbi.nlm.nih.gov/36201165
Autor:
Leticia K. Lerner, Carlos Frederico Martins Menck, Mahwish Mian Mohammad, Alain Sarasin, Veridiana Munford, Ligia Pereira Castro, Thuy Vy Nguyen, Juliana B. Vilar, Filippo Rosselli, Said Aoufouchi, Veronique Vergé, Morwenna Le Guillou
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
Scientific Reports
Scientific Reports, Nature Publishing Group, 2020, 10 (1), ⟨10.1038/s41598-020-58180-7⟩
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Scientific Reports
Scientific Reports, Nature Publishing Group, 2020, 10 (1), ⟨10.1038/s41598-020-58180-7⟩
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Somatic hypermutation of immunoglobulin genes is a highly mutagenic process that is B cell-specific and occurs during antigen-driven responses leading to antigen specificity and antibody affinity maturation. Mutations at the Ig locus are initiated by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69714685788ded8e74775c696be623aa
http://link.springer.com/article/10.1038/s41598-020-58180-7
http://link.springer.com/article/10.1038/s41598-020-58180-7
Autor:
Jean-Marie Michot, Cyril Quivoron, Clémentine Sarkozy, Alina Danu, Julien Lazarovici, Khalil Saleh, Yolla El-Dakdouki, Vincent Goldschmidt, Camille Bigenwald, Matteo Dragani, Rastislav Bahleda, Capucine Baldini, Julia Arfi-Rouche, Patricia Martin-Romano, Lambros Tselikas, Anas Gazzah, Antoine Hollebecque, Ludovic Lacroix, David Ghez, Veronique Vergé, Christophe Marzac, Sophie Cotteret, Wassila Rahali, Jean-Charles Soria, Christophe Massard, Olivier A. Bernard, Peggy Dartigues, Valérie Camara-Clayette, Vincent Ribrag
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::71c291d749d32fce7c73d8413df39b78
https://doi.org/10.2139/ssrn.4057122
https://doi.org/10.2139/ssrn.4057122
Autor:
Fabrice Barlesi, David Planchard, Vincent Ribrag, Jose Carlos Benitez, Y. Loriot, Luc Friboulet, C. Naltet, Veronique Vergé, F.G. Dall'Olio, Pamela Abdayem, Benjamin Besse, J-C. Soria, Cyril Quivoron, Mihaela Aldea, Helene Lecourt, M.R. Ghigna, Pernelle Lavaud, S. de Botton, C. Parisi, F. Blanc-Durand
Publikováno v:
Annals of Oncology. 32:S956-S957
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf6e385012c31a21499701f627c87063
https://doi.org/10.1016/j.annonc.2021.08.1803
https://doi.org/10.1016/j.annonc.2021.08.1803
Autor:
Laurence Albiges, Fanny Pommeret, David Ghez, Stéphanie Foulon, Franck Griscelli, Clémentine Bouchez, Arnaud Bayle, Thomas Hueso, Flore Salviat, Emmanuelle Gallois, Valérie Boige, Veronique Vergé
Publikováno v:
British Journal of Haematology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbb7a15363e42e8eeba6545af2b9d82b
Autor:
Loic Ysebaert, C. Bret, Lucile Baseggio, Thierry Fest, Peggy Dartigues, L. Naiglin, M. Anquetin, Roch Houot, Valérie Camara-Clayette, P. Gaulard, G. Cartron, Vanessa Szablewski, P. Brousset, Gilles Salles, E. Gomez, Céline Pangault, Jehan Dupuis, B. Ghaleh, C. Barau, K. Da Cunha, Camille Laurent, Vincent Ribrag, G. Brisou, G. Uze, Veronique Vergé, E. Mollaret, Jérôme Moreaux, V. Thouault, Pauline Gravelle, O. Karmous-Gadacha, Bertrand Nadel
Publikováno v:
Hematological Oncology. 37:370-372
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10b3c460f37dad2d5d238cca7e255461
https://doi.org/10.1002/hon.38_2631
https://doi.org/10.1002/hon.38_2631
Autor:
Cyril Quivoron, David Ghez, Julien Rossignol, Veronique Vergé, Julien Lazarovici, Alina Danu, Vincent Ribrag, Jean-Marie Michot, Véronique Saada, Helene Lecourt
Publikováno v:
Blood. 138:3763-3763
Background: Despite recent advances in the treatment of multiple myeloma (MM) patients, cure remains rare. MM is in an era of intense clinical research and the molecular abnormalities landscape of refractory and relapsed (R/R) patients is of major in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e871d65fa91a81484b1ab350001d1c8
https://doi.org/10.1182/blood-2021-149369
https://doi.org/10.1182/blood-2021-149369